These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain. Nabulsi NB, Mercier J, Holden D, Carré S, Najafzadeh S, Vandergeten MC, Lin SF, Deo A, Price N, Wood M, Lara-Jaime T, Montel F, Laruelle M, Carson RE, Hannestad J, Huang Y. J Nucl Med; 2016 May; 57(5):777-84. PubMed ID: 26848175 [Abstract] [Full Text] [Related]
4. In vivo imaging of synaptic SV2A protein density in healthy and striatal-lesioned rats with [11C]UCB-J PET. Thomsen MB, Jacobsen J, Lillethorup TP, Schacht AC, Simonsen M, Romero-Ramos M, Brooks DJ, Landau AM. J Cereb Blood Flow Metab; 2021 Apr; 41(4):819-830. PubMed ID: 32538280 [Abstract] [Full Text] [Related]
6. Quantifying SV2A density and drug occupancy in the human brain using [11C]UCB-J PET imaging and subcortical white matter as reference tissue. Koole M, van Aalst J, Devrome M, Mertens N, Serdons K, Lacroix B, Mercier J, Sciberras D, Maguire P, Van Laere K. Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):396-406. PubMed ID: 30121895 [Abstract] [Full Text] [Related]
8. Synaptic density in healthy human aging is not influenced by age or sex: a 11C-UCB-J PET study. Michiels L, Delva A, van Aalst J, Ceccarini J, Vandenberghe W, Vandenbulcke M, Koole M, Lemmens R, Laere KV. Neuroimage; 2021 May 15; 232():117877. PubMed ID: 33639258 [Abstract] [Full Text] [Related]
9. In vivo imaging of synaptic density with [11C]UCB-J PET in two mouse models of neurodegenerative disease. Xiong M, Roshanbin S, Rokka J, Schlein E, Ingelsson M, Sehlin D, Eriksson J, Syvänen S. Neuroimage; 2021 Oct 01; 239():118302. PubMed ID: 34174391 [Abstract] [Full Text] [Related]
11. Reduced synaptic vesicle protein 2A binding in temporal lobe epilepsy: A [11 C]UCB-J positron emission tomography study. Finnema SJ, Toyonaga T, Detyniecki K, Chen MK, Dias M, Wang Q, Lin SF, Naganawa M, Gallezot JD, Lu Y, Nabulsi NB, Huang Y, Spencer DD, Carson RE. Epilepsia; 2020 Oct 01; 61(10):2183-2193. PubMed ID: 32944949 [Abstract] [Full Text] [Related]
19. A metabolically stable PET tracer for imaging synaptic vesicle protein 2A: synthesis and preclinical characterization of [18F]SDM-16. Zheng C, Holden D, Zheng MQ, Pracitto R, Wilcox KC, Lindemann M, Felchner Z, Zhang L, Tong J, Fowles K, Finnema SJ, Nabulsi N, Carson RE, Huang Y, Cai Z. Eur J Nucl Med Mol Imaging; 2022 Apr 01; 49(5):1482-1496. PubMed ID: 34761284 [Abstract] [Full Text] [Related]
20. Evaluation of 18F-UCB-H as a novel PET tracer for synaptic vesicle protein 2A in the brain. Warnock GI, Aerts J, Bahri MA, Bretin F, Lemaire C, Giacomelli F, Mievis F, Mestdagh N, Buchanan T, Valade A, Mercier J, Wood M, Gillard M, Seret A, Luxen A, Salmon E, Plenevaux A. J Nucl Med; 2014 Aug 01; 55(8):1336-41. PubMed ID: 24935992 [Abstract] [Full Text] [Related] Page: [Next] [New Search]